Researchers from Sylvester Comprehensive Cancer Center and Dana Farber Cancer Institute have received a $4 million five-year grant from NCI to determine whether lifestyle interventions, such as exercise and intermittent fasting, help patients with advanced breast cancer better tolerate side effects from treatment.
Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center have formed a comprehensive collaboration designed to advance cancer care and build the region’s only independent, free-standing inpatient hospital for adult cancer patients.
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Dana Farber Cancer Institute have received $7 million from the Patient-Centered Outcomes Research Institute to study how diet and exercise impact mental and physical functioning in older cancer survivors and their caregivers.
A clinical study testing revumenib, a novel targeted treatment, found 40% of patients with acute leukemia had complete response and showed how the cancer cells resist the drug, investigators at Dana-Farber Cancer Institute and other research centers report in a new pair of studies in the journal Nature.
The Parker Institute for Cancer Immunotherapy, a network of the largest concentration of immuno-oncology expertise in the world, has added Dana-Farber Cancer Institute and Gladstone Institutes to its network of academic and medical research institutions.
Researchers have compiled a comprehensive genetic architecture atlas for mutant RAS genes in human cancers.
Don’t sack the director because your cancer center’s score and ranking by U.S. News & World Report have slipped.
The Richard K. Lubin Family Foundation will provide a grant to establish the Lubin Family Foundation Scholar Awards at Dana-Farber Cancer Institute.
Researchers from the Dana-Farber Cancer Institute and the Tisch Cancer Institute at Mount Sinai Medical School showed that the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care in 2021, although patient recruitment increased in 2021.
Dana-Farber Cancer Institute, Gustave Roussy, and L’Institut Servier signed a cooperation agreement to foster collaboration among oncology researchers.
